c-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by

Petia P Simeonova1, Shiyi Wang, Tracy Hulderman

  • 1TMBB, HELD, National Institute for Occupational Safety and Health, Centers for Disease Control, Morgantown, West Virginia 26505, USA. PSimeonova@cdc.gov

Insights

Arsenic exposure activates the epidermal growth factor receptor (EGFR) and extracellular signal-regulated kinase (ERK) pathway, a key regulator of cell growth. This activation, involving c-Src, may mediate arsenic-induced changes in the urinary tract lining.

Area of Science:

  • Environmental toxicology
  • Cancer research
  • Cell signaling

Background:

  • Arsenic exposure is linked to increased cancer risk, particularly in the skin, urinary bladder, and respiratory tract.
  • Arsenic acts as a tumor promoter by influencing cell proliferation pathways.
  • The epidermal growth factor receptor (EGFR)-extracellular signal-regulated protein kinase (ERK) pathway is crucial for regulating cellular growth.

Purpose of the Study:

  • To investigate the mechanism by which arsenic activates EGFR and ERK signaling in human uroepithelial cells.
  • To determine the role of c-Src in arsenic-induced EGFR and ERK activation.
  • To examine the in vivo relevance of these findings in a mouse model of arsenic exposure.

Main Methods:

  • In vitro studies using a human uroepithelial cell line exposed to arsenic.
  • Analysis of EGFR and ERK phosphorylation, and c-Src activity.
  • In vivo studies involving mice exposed to arsenic in drinking water.
  • Assessment of EGFR, ERK, and c-Src in mouse urinary bladders.

Main Results:

  • Arsenic activates EGFR and ERK in human uroepithelial cells in a ligand-independent manner.
  • Arsenic-induced EGFR activation does not involve the Tyr(1173) autophosphorylation site.
  • c-Src activity is induced by arsenic and is essential for EGFR and ERK activation.
  • In mice, arsenic exposure activates EGFR and ERK in the urinary bladder, increasing c-Src interaction with EGFR.

Conclusions:

  • Arsenic activates the EGFR-ERK pathway in urothelial cells via ligand-independent mechanisms involving c-Src.
  • These findings suggest a molecular pathway through which arsenic exposure can lead to phenotypic alterations in the uroepithelium.
  • The study provides insights into the mechanisms underlying arsenic-induced urothelial carcinogenesis.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...